Fig. 1From: Identification of prognostic and therapeutic biomarkers in type 2 papillary renal cell carcinomaOverall survival and disease-free survival of PRCC2 compared with PRCC1 (A-B). Tumor stage and lymph node stage of two kinds of PRCC (C-D). Mutation landscape of PRCC (E)Back to article page